Choline Fenofibrate
A PPARα agonist used for treatment of hyperlipidemia; increases SHP gene expression in cultured liver cells and in the normal and diabetic mouse liver by activating AMPK signaling pathway.Hypercholesterolemia Approved (In Vivo) :Choline Fenofibrate exhibits excellent absolute oral bioavailability (rat 93.4%) and Cmax (rat 7944.2 ng/mL) following oral administration (rat 4mg/kg) .Choline Fenofibrate exhibits terminal elimination half-life (rat 5.4 h) following intravenous injection (rat 4mg/kg) .
Product Specifications
CAS Number
856676-23-8
Product Name Alternative
ABT-335 | ABT 335 | ABT335
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 6.2 mg/mL (Need ultrasonic and warming)
Smiles
OCC[N+] (C) (C) C.CC (C) (OC1=CC=CC=C1C (C2=CC=C (Cl) C=C2) =O) C ([O-]) =O
Molecular Formula
C22H28ClNO5
Molecular Weight
421.9144
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Ethanaminium, 2-hydroxy-N, N, N-trimethyl-, 2-[4- (4-chlorobenzoyl) phenoxy]-2-methylpropanoate (1:1)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ABCA6 (ATP-binding Cassette Sub-family A Member 6) (AP) discontinued
SULT1C2, NT (Sulfotransferase 1C4, ST1C4, Sulfotransferase 1C2, SULT1C#2, SULT1C4) (Biotin)
SULT1C2, NT (Sulfotransferase 1C4, ST1C4, Sulfotransferase 1C2, SULT1C#2, SULT1C4) (Biotin)
